A MULTICENTER, PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PILOT STUDY ON THE BENEFIT/COST/SAFETY PROFILE OF SOFOSBUVIR FOR SYMPTOMATIC MIXED CRYOGLOBULINEMIA (Studio pilota multicentrico, prospettico, a singolo braccio, in aperto, dei profili costi / benefici / sicurezza del sofosbuvir effettuato su pazienti con infezione cronica da virus dell'epatite C (HCV) e crioglobulinemia mista sintomatica)

Trial Profile

A MULTICENTER, PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PILOT STUDY ON THE BENEFIT/COST/SAFETY PROFILE OF SOFOSBUVIR FOR SYMPTOMATIC MIXED CRYOGLOBULINEMIA (Studio pilota multicentrico, prospettico, a singolo braccio, in aperto, dei profili costi / benefici / sicurezza del sofosbuvir effettuato su pazienti con infezione cronica da virus dell'epatite C (HCV) e crioglobulinemia mista sintomatica)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms sof-crio
  • Most Recent Events

    • 20 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top